Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk	Events
other	hypoaesthesia oral	Gastrointestinal disorders	TNX-102 SL 2.8 mg Tablets	45	103
other	hypoaesthesia oral	Gastrointestinal disorders	Placebo	2	101
other	Nausea	Gastrointestinal disorders	TNX-102 SL 2.8 mg Tablets	5	103
other	Nausea	Gastrointestinal disorders	Placebo	2	101
other	Somnolence	Nervous system disorders	TNX-102 SL 2.8 mg Tablets	2	103
other	Somnolence	Nervous system disorders	Placebo	7	101
other	Back pain	Musculoskeletal and connective tissue disorders	TNX-102 SL 2.8 mg Tablets	5	103
other	Back pain	Musculoskeletal and connective tissue disorders	Placebo	3	101
other	Product taste abnormal	General disorders	TNX-102 SL 2.8 mg Tablets	8	103
other	Product taste abnormal	General disorders	Placebo	0	101
serious	CHOLECYSTITIS	Hepatobiliary disorders	TNX-102 SL 2.8 mg Tablets	0	103	0
serious	CHOLECYSTITIS	Hepatobiliary disorders	Placebo	1	101	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01903265/events